Published in Endocrinology on March 01, 1971
Metabolism of proinsulin, insulin, and C-peptide in the rat. J Clin Invest (1973) 1.60
Kinetics of human connecting peptide in normal and diabetic subjects. J Clin Invest (1978) 1.42
The metabolism of proinsulin and insulin by the liver. J Clin Invest (1972) 1.38
Direct measurement of proinsulin in human plasma by the use of an insulin-degrading enzyme. J Clin Invest (1971) 0.95
The interactions of proinsulin with insulin receptors on the plasma membrane of the liver. J Clin Invest (1974) 0.91
Peripheral metabolism of insulin, proinsulin, and C-peptide in the pregnant rat. J Clin Invest (1975) 0.83
Proinsulin slows retinal degeneration and vision loss in the P23H rat model of retinitis pigmentosa. Hum Gene Ther (2012) 0.81
Expression and secretion of human proinsulin-B10 from mouse salivary glands: implications for the treatment of type I diabetes mellitus. PLoS One (2013) 0.79
The effect of epinephrine on immunoreactive insulin levels in man. J Clin Invest (1966) 4.92
A sensitive radioenzymatic assay for norepinephrine in tissues and plasma. Life Sci (1975) 4.32
An ultrastructural analysis of the developing embryonic pancreas. Dev Biol (1972) 3.00
Foam elastomer dressing in the management of open granulating wounds: experience with 250 patients. Br J Surg (1977) 2.83
Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab (1976) 2.39
Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes (1990) 2.00
Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal. J Clin Invest (1994) 1.79
Inhibition of insulin release by norepinephrine in man. Science (1966) 1.78
Nucleotide sequence of cucumber-mosaic-virus RNA 2 reveals a translation product significantly homologous to corresponding proteins of other viruses. Eur J Biochem (1984) 1.76
Malignant Tumors of the Small Intestine. Am J Pathol (1937) 1.67
Mycophenolic acid: antiviral and antitumor properties. J Antibiot (Tokyo) (1968) 1.65
Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med (1989) 1.59
Pre-operative intravenous feeding--a controlled trial. Postgrad Med J (1979) 1.57
Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care (1984) 1.48
Cholecystokinin is a physiological regulator of gastric acid secretion in man. Eur J Clin Invest (1994) 1.45
Effect of glucagon on serum insulin, plasma glucose and free fatty acids in man. Metabolism (1966) 1.41
Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects. J Clin Invest (1976) 1.40
Insulin, glucagon, and glucose exhibit synchronous, sustained oscillations in fasting monkeys. Science (1977) 1.39
Aggressive approach in the treatment of acute lead encephalopathy with an extraordinarily high concentration of lead. Arch Pediatr Adolesc Med (1998) 1.38
The Wolff-Parkinson-White syndrome: problems in evaluation and surgical therapy. Circulation (1970) 1.31
The reversibility of anabolic steroid-induced azoospermia. J Urol (1995) 1.30
Elevated plasma glucose and lowered triglyceride levels from omega-3 fatty acid supplementation in type II diabetes. Diabetes Care (1989) 1.29
The effect of adrenergic blockade on the glucagon responses to starvation and hypoglycemia in man. J Clin Invest (1974) 1.29
Proceedings: A randomized controlled trial of preoperative intravenous nutrition in patients with stomach cancer. Br J Surg (1976) 1.27
Are research subjects really informed? West J Med (1975) 1.26
Early differentiation of glucagon-producing cells in embryonic pancreas: a possible developmental role for glucagon. Proc Natl Acad Sci U S A (1973) 1.26
Fibrinogen-transmitted hepatitis in the surgical patient. Ann Surg (1969) 1.24
Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goitre. Lancet (1990) 1.23
Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse. Diabetes (1994) 1.21
Studies of the insulin-like actions of thiols upon isolated fat cells. J Biol Chem (1970) 1.20
Nucleotide sequence of cucumber mosaic virus RNA. 1. Presence of a sequence complementary to part of the viral satellite RNA and homologies with other viral RNAs. Eur J Biochem (1985) 1.20
Hemodynamic and single nephron function during the maintenance phase of ischemic acute renal failure in the dog. Kidney Int (1981) 1.16
Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons. J Clin Invest (1996) 1.16
In vitro antiviral activity of mycophenolic acid and its reversal by guanine-type compounds. Appl Microbiol (1969) 1.15
Isolation of human intestinal neurotensin. J Biol Chem (1980) 1.14
Clearance of porcine insulin, proinsulin, and connecting peptide by the isolated rat liver. Proc Soc Exp Biol Med (1970) 1.14
Arginine-stimulated acute phase of insulin and glucagon secretion. I. in normal man. Diabetes (1975) 1.13
Plasma norepinephrine responses of man in cold water. J Appl Physiol Respir Environ Exerc Physiol (1977) 1.13
Effect of blood glucose on glucagon secretion in anesthetized dogs. Diabetes (1969) 1.09
Incorporation of l-[3H]fucose and d-[3H]glucosamine into cell-surface-associated glycoconjugates in epidermis of cultured pig skin slices. Biochem J (1980) 1.08
Enteral enhancement of glucose disposition by both insulin-dependent and insulin-independent processes. A physiological role of glucagon-like peptide I. Diabetes (1995) 1.08
Why do physicians stop practicing obstetrics? The impact of malpractice claims. Obstet Gynecol (1990) 1.08
Evidence for high levels of vertical transmission in Toxoplasma gondii. Parasitology (2009) 1.08
Fibroblast monolayer cultures in scintillation counting vials: metabolic and growth experiments using radioisotopes and a microfluoremetric DNA assay. In Vitro (1977) 1.08
Prodigiosene [5-(2-pyrryl)-2,2-'-dipyrrylmethene] and some substituted prodigiosenes. J Org Chem (1970) 1.08
Mass Mortality of Marine Animals on the Lower West Coast of Florida, November 1946-January 1947. Science (1947) 1.07
Pancreatic glucagon release and sulphonylureas. Lancet (1969) 1.07
The evaluation of the incentive spirometer in the management of postoperative pulmonary complications. Br J Surg (1974) 1.07
Inorganic membranes for hydrogen production and purification: a critical review and perspective. J Colloid Interface Sci (2007) 1.06
Evidence for the existence of 5-hydroxytryptamine receptors, which are not of the 5-HT2 type, mediating contraction of rabbit isolated basilar artery. Br J Pharmacol (1986) 1.05
Thiouracil in the Preparation of Thyrotoxic Patients for Surgery. Ann Surg (1944) 1.05
Pathophysiology of acute Bence-Jones protein nephrotoxicity in the rat. Kidney Int (1981) 1.04
Use of benzamidine as a proteolytic inhibitor in the radioimmunoassay of glucagon in plasma. J Clin Endocrinol Metab (1972) 1.03
Studies on the action of insulin in isolated adipose tissue cells. II. 3',5'-Nucleotide phosphodiesterase and antilipolysis. Biochim Biophys Acta (1969) 1.02
Secretion, fates and actions of insulin and related products. Diabetes (1966) 1.02
Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter. Am J Med (1990) 1.01
Somatostatin inhibition of insulin and glucagon secretion in rat islet culture: reversal by ionophore A23187. Endocrinology (1976) 1.01
Open heart surgery iinfeive endocarditis. Circulation (1970) 1.00
Human deficiencies of vitamin B6. I. Studies on parameters of the assay of the glutamic oxaloacetic transaminase by the CAS principle. Res Commun Chem Pathol Pharmacol (1975) 1.00
Respiration in isolated fat cells and the effects of epinephrine. J Biol Chem (1968) 1.00
Familial nesidioblastosis as the predominant manifestation of multiple endocrine adenomatosis. Am J Med (1972) 1.00
Nesidioblastosis in familial endocrine adenomatosis. JAMA (1969) 0.99
Lipid composition of the superficial stratum corneum cells of pig epidermis. Br J Dermatol (1982) 0.99
Insulin and glucagon responses in subjects with pheochromocytoma: effect of alpha adrenergic blockade. J Clin Endocrinol Metab (1969) 0.99
A double antibody immunoassay for glucagon. Diabetes (1968) 0.99
Glucagon clearance by the isolated perfused rat liver. Proc Soc Exp Biol Med (1968) 0.98
Glucagon response to hypoglycemia in sympathectomized man. J Clin Invest (1976) 0.98
Chlorpropamide treatment in diabetes insipidus. Lancet (1967) 0.97
Method for measuring hormonal effects on conversion of adenosine triphosphate to adenosine 3', 5'-monophosphate by isolated lipocytes. Metabolism (1968) 0.97
Insulin response to glucagon. The opposing effects of diabetes and obesity. Diabetes (1969) 0.97
Glucagon and catecholamine secretion during hypoglycemia in normal and diabetic man. J Clin Endocrinol Metab (1977) 0.97
Cystic medial necrosis with and without Marfan's syndrome. Surgical experience with 20 patients and a note about the modified bicuspidization operation. Surg Clin North Am (1967) 0.97
Pitfalls in interpreting prostate specific antigen velocity. J Urol (1996) 0.97
Underestimation of cardiac output by thermodilution in patients with tricuspid regurgitation. Am J Med (1989) 0.96
Tryptamine-induced vasoconstrictor responses in rat caudal arteries are mediated predominantly via 5-hydroxytryptamine receptors. Br J Pharmacol (1985) 0.96
The relation between postheparin lipolytic activity and plasma triglyceride in myxedema. Metabolism (1966) 0.96
Use of constant composition polyvinylpyrrolidone columns to study the interaction of fat particles with plasma. J Lipid Res (1966) 0.96
Effect of starvation on plasma immunoreactive insulin and non-suppressible insulin-like activity in normal and obese humans. Metabolism (1968) 0.96
Uninhibited thyroidal uptake of radioiodine despite iodine excess in amiodarone-induced hypothyroidism. J Clin Endocrinol Metab (1986) 0.95
Neurohumoral regulation of the pancreatic islet A and B cells. Metabolism (1976) 0.95
Clinical use of diazoxide and studies of the mechanism of its hyperglycemic effects in man. Ann N Y Acad Sci (1968) 0.95
Studies on the action of insulin in isolated adipose tissue cells. I. Stimulation of incorporation of 32P-labeled inorganic phosphate into mononucleotides in the absence of glucose. J Biol Chem (1968) 0.95
Low molecular weight analogs of coenzyme Q as hydrogen acceptors and donors in systems of the respiratory chain. Biochem Biophys Res Commun (1975) 0.95
Evidence that primary infection of Charollais sheep with Toxoplasma gondii may not prevent foetal infection and abortion in subsequent lambings. Parasitology (2007) 0.94
Acute-phase insulin secretion and glucose tolerance in young and aged normal men and diabetic patients. J Clin Endocrinol Metab (1975) 0.94
Effects of glucagonlike peptide I-(7-36) on release of insulin, glucagon, and somatostatin by rat pancreatic islet cell monolayer cultures. Diabetes (1989) 0.94
Significant familial differences in the frequency of abortion and Toxoplasma gondii infection within a flock of Charollais sheep. Parasitology (2005) 0.94
The influence of beta-adrenoceptor blocking agents on plasma thyroxine and triiodothyronine. J Clin Endocrinol Metab (1977) 0.93
Clinical use of diazoxide and mechanism for its hyperglycemic effects. Diabetes (1966) 0.93
Lipolytic effects of high concentrations of insulin on isolated fat cells. Enhancement of the response to lipolytic hormones. Diabetes (1973) 0.93
Apparent deficiency of vitamin B6 in typical individuals who commonly serve as normal controls. Res Commun Chem Pathol Pharmacol (1976) 0.92
Somatostatin 28 and coupling of human interdigestive intestinal motility and pancreatic secretion. Gastroenterology (1992) 0.92